MIRAGEN THERAPEUTICS, INC. — Form D/A
MIRAGEN THERAPEUTICS, INC. of BOULDER, CO, a company, filed a Form D amendment with the SEC on 2019-10-31. The offering totals $5.0M, of which $1.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-10-31
- Form: D/A
- Accession: 0001590750-19-000052
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $1.5M
- Remaining: $3.5M
- Investors: 1
- Date of first sale: 2018-08-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-318573
Issuer
- Name: MIRAGEN THERAPEUTICS, INC.
- CIK: 0001590750
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 6200 LOOKOUT ROAD, BOULDER, CO, 80301
- Phone: 303-531-5952
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Christopher D Bowden | Director | Boulder, CO |
| Thomas E Hughes | Director | Boulder, CO |
| Kevin E Koch | Director | Boulder, CO |
| William S Marshall | Director | San Francisco, CA |
| Joseph L Turner | Director | Mountain View, CA |
| William S Marshall | Executive Officer | San Francisco, CA |
| Paul D Rubin | Executive Officer | Boulder, CO |
| Jonathan Violin | Executive Officer | Waltham, MA |
| Joesph L Turner | Director | Boulder, CO |
| Lee M Rauch | Director | Boulder, CO |
| Lee M Rauch | Executive Officer | Boulder, CO |
| Diana A Escolar | Executive Officer | Boulder, CO |
| Jeffrey S Hatfield | Director | Boulder, CO |
| Peter E Harwin | Director | Boulder, CO |
| Tomas E Kiselak | Director | Boulder, CO |
| Arlene M Morris | Director | Boulder, CO |
| Christopher L Bowden | Director | Boulder, CO |
| Joseph L Tuner | Director | Boulder, CO |
| Jason A Leverone | Executive Officer | Boulder, CO |
| Adam S Levy | Executive Officer | Boulder, CO |
| Bruce L Booth | Director | Boulder, CO |
Other filings by this issuer (3)
More